High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Carén, Helena ^a   Erichsen, Jennie ^a   Olsson, Linda ^a   Enerbäck, Charlotta ^a   Sjöberg, Rose Marie ^a   Abrahamsson, Jonas ^b   Kogner, Per ^c   Martinsson, Tommy ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; OLIGONUCLEOTIDE; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ALLELE; AMPLICON; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 12; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 1; CHROMOSOME DELETION 11; CHROMOSOME DELETION 3; CHROMOSOME DELETION 9; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; COMPUTER PROGRAM; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE MAPPING; GENE REARRANGEMENT; GENETIC GAIN; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NEUROBLASTOMA; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; CHILD; CHROMOSOME 9; CHROMOSOME MAP; DNA MICROARRAY; GENE DOSAGE; GENETICS; HOMOZYGOTE; LIGASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CHILD; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE REARRANGEMENT; HOMOZYGOTE; HUMANS; LIGASE CHAIN REACTION; LOSS OF HETEROZYGOSITY; NEUROBLASTOMA; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 50849086751     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-353     Document Type: Article

References (61)

1. Gilbert F Feder M Balaban G Brangman D Lurie DK Podolsky R Rinaldt V Vinikoor N Weisband J Human neuroblastomas and abnormalities of chromosomes 1 and 17 Cancer Res 1984, 44(11):5444-5449. 6488196
2. Schwab M Alitalo K Klempnauer KH Varmus HE Bishop JM Gilbert F Brodeur G Goldstein M Trent J Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour Nature 1983, 305(5931):245-248. 10.1038/305245a0 6888561
3. Srivatsan ES Ying KL Seeger RC Deletion of chromosome 11 and of 14q sequences in neuroblastoma Genes Chromosomes Cancer 1993, 7(1):32-37. 10.1002/gcc.2870070106 7688553
4. Suzuki T Yokota J Mugishima H Okabe I Ookuni M Sugimura T Terada M Frequent loss of heterozygosity on chromosome 14q in neuroblastoma Cancer Res 1989, 49(5):1095-1098. 2563671
5. Brodeur GM Neuroblastoma: Biological insights into a clinical enigma Nature reviews 2003, 3(3):203-216. 10.1038/nrc1014 12612655
6. Vandesompele J Speleman F Van Roy N Laureys G Brinskchmidt C Christiansen H Lampert F Lastowska M Bown N Pearson A Nicholson JC Ross F Combaret V Delattre O Feuerstein BG Plantaz D Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there? Med Pediatr Oncol 2001, 36(1):5-10. 10.1002/ 1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E 11464905
7. Brodeur GM Sekhon G Goldstein MN Chromosomal aberrations in human neuroblastomas Cancer 1977, 40(5):2256-2263. 10.1002/ 1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1 922665
8. Mosse YP Greshock J Weber BL Maris JM Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era Cancer Lett 2005, 228(1-2):83-90. 10.1016/j.canlet.2005.02.052 15967571
9. Mosse YP Diskin SJ Wasserman N Rinaldi K Attiyeh EF Cole K Jagannathan J Bhambhani K Winter C Maris JM Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression Genes Chromosomes Cancer 2007, 46(10):936-949. 10.1002/gcc.20477 17647283
10. Scaruffi P Valent A Schramm A Astrahantseff K Eggert A Tonini GP Application of microarray-based technology to neuroblastoma Cancer Lett 2005, 228(1-2):13-20. 10.1016/j.canlet.2005.01.052 15951106
11. Scaruffi P Coco S Cifuentes F Albino D Nair M Defferrari R Mazzocco K Tonini GP Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization Cancer Genet Cytogenet 2007, 177(1):20-29. 10.1016/ j.cancergencyto.2007.05.002 17693187
12. Selzer RR Richmond TA Pofahl NJ Green RD Eis PS Nair P Brothman AR Stallings RL Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH Genes Chromosomes Cancer 2005, 44(3):305-319. 10.1002/gcc.20243 16075461
13. De Preter K Pattyn F Berx G Strumane K Menten B Van Roy F De Paepe A Speleman F Vandesompele J Combined subtractive cDNA cloning and array CGH: An efficient approach for identification of overexpressed genes in DNA amplicons BMC Genomics 2004, 5(1):11. 365025 15018647 10.1186/ 1471-2164-5-11
14. Chen QR Bilke S Khan J High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma Cancer Lett 2005, 228(1-2):71-81. 10.1016/j.canlet.2004.12.056 15951107
15. Chen QR Bilke S Wei JS Whiteford CC Cenacchi N Krasnoselsky AL Greer BT Son CG Westermann F Berthold F Schwab M Catchpoole D Khan J cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma BMC Genomics 2004, 5(1):70. 520814 15380028 10.1186/1471-2164-5-70
16. Michels E Vandesompele J Hoebeeck J Menten B De Preter K Laureys G Van Roy N Speleman F Genome wide measurement of DNA copy number changes in neuroblastoma: Dissecting amplicons and mapping losses, gains and breakpoints Cytogenet Genome Res 2006, 115(3-4):273-282. 10.1159/ 000095924 17124410
17. Spitz R Oberthuer A Zapatka M Brors B Hero B Ernestus K Oestreich J Fischer M Simon T Berthold F Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome Genes Chromosomes Cancer 2006, 45(12):1130-1142. 10.1002/gcc.20376 16958102
18. Takeda O Homma C Maseki N Sakurai M Kanda N Schwab M Nakamura Y Kaneko Y There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma Genes Chromosomes Cancer 1994, 10(1):30-39. 10.1002/gcc.2870100106 7519871
19. Caron H van Sluis P de Kraker J Bokkerink J Egeler M Laureys G Slater R Westerveld A Voute PA Versteeg R Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma N Engl J Med 1996, 334(4):225-230. 10.1056/NEJM199601253340404 8531999
20. Caron H Peter M van Sluis P Speleman F de Kraker J Laureys G Michon J Brugieres L Voute PA Westerveld A Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: One probably imprinted, another associated with N-myc amplification Hum Mol Genet 1995, 4(4):535-539. 10.1093/hmg/4.4.535 7633401
21. Caron H Spieker N Godfried M Veenstra M van Sluis P de Kraker J Voute P Versteeg R Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted Genes Chromosomes Cancer 2001, 30(2):168-174. 10.1002/ 1098-2264(200102)30:2<168::AID-GCC1072>3.0.CO;2-E 11135433
22. Ejeskär K Sjöberg R-M Abel F Kogner P Ambros PF Martinsson T Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours Med Pediatr Oncol 2001, 36(1):61-66. 10.1002/ 1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO;2-0 11464908
23. Maris JM Guo C Blake D White PS Hogarty MD Thompson PM Rajalingam V Gerbing R Stram DO Matthay KK Seeger RC Brodeur GM Comprehensive analysis of chromosome 1p deletions in neuroblastoma Med Pediatr Oncol 2001, 36(1):32-36. 10.1002/ 1096-911X(20010101)36:1<32::AID-MPO1009>3.0.CO;2-0 11464900
24. Maris JM White PS Beltinger CP Sulman EP Castleberry RP Shuster JJ Look AT Brodeur GM Significance of chromosome 1p loss of heterozygosity in neuroblastoma Cancer Res 1995, 55(20):4664-4669. 7553646
25. Bauer A Savelyeva L Claas A Praml C Berthold F Schwab M Smallest region of overlapping deletion in 1p36 in human neuroblastoma: A 1 Mbp cosmid and PAC contig Genes Chromosomes Cancer 2001, 31(3):228-239. 10.1002/ gcc.1139 11391793
26. Martinsson T Sjoberg RM Hedborg F Kogner P Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma Cancer Genet Cytogenet 1997, 95(2):183-189. 10.1016/ S0165-4608(96)00259-2 9169039
27. Martinsson T Sjöberg R-M Hedborg F Kogner P Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms Cancer Res 1995, 55(23):5681-5686. 7585654
28. Spieker N Beitsma M Van Sluis P Chan A Caron H Versteeg R Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1 Genes Chromosomes Cancer 2001, 31(2):172-181. 10.1002/ gcc.1130 11319804
29. White PS Maris JM Beltinger C Sulman E Marshall HN Fujimori M Kaufman BA Biegel JA Allen C Hilliard C A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3 Proc Natl Acad Sci USA 1995, 92(12):5520-5524. 41727 7777541 10.1073/pnas.92.12.5520
30. White PS Thompson PM Seifried BA Sulman EP Jensen SJ Guo C Maris JM Hogarty MD Allen C Biegel JA Matise TC Gregory SG Reynolds CP Brodeur GM Detailed molecular analysis of 1p36 in neuroblastoma Med Pediatr Oncol 2001, 36(1):37-41. 10.1002/ 1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L 11464901
31. White PS Thompson PM Gotoh T Okawa ER Igarashi J Kok M Winter C Gregory SG Hogarty MD Maris JM Brodeur GM Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma Oncogene 2005, 24(16):2684-2694. 10.1038/sj.onc.1208306 15829979
32. Guo C White PS Weiss MJ Hogarty MD Thompson PM Stram DO Gerbing R Matthay KK Seeger RC Brodeur GM Maris JM Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas Oncogene 1999, 18(35):4948-4957. 10.1038/sj.onc.1202887 10490829
33. Origone P Defferrari R Mazzocco K Lo Cunsolo C De Bernardi B Tonini GP Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma Am J Med Genet A 2003, 118(4):309-313. 10.1002/ajmg.a.10167
34. Thompson PM Maris JM Hogarty MD Seeger RC Reynolds CP Brodeur GM White PS Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma Cancer Res 2001, 61(2):679-686. 11212268
35. Munoz J Lazcoz P Inda MM Nistal M Pestana A Encio IJ Castresana JS Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines Int J Cancer 2004, 109(5):673-679. 10.1002/ ijc.20055 14999773
36. Ohira M Kageyama H Mihara M Furuta S Machida T Shishikura T Takayasu H Islam A Nakamura Y Takahashi M Tomioka N Sakiyama S Kaneko Y Toyoda A Hattori M Sakaki Y Ohki M Horii A Soeda E Inazawa J Seki N Kuma H Nozawa I Nakagawara A Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line Oncogene 2000, 19(37):4302-4307. 10.1038/sj.onc.1203786 10980605
37. Teitz T Wei T Valentine MB Vanin EF Grenet J Valentine VA Behm FG Look AT Lahti JM Kidd VJ Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nat Med 2000, 6(5):529-535. 10.1038/75007 10802708
38. Rocco JW Sidransky D p16(MTS-1/CDKN2/INK4a) in cancer progression Exp Cell Res 2001, 264(1):42-55. 10.1006/excr.2000.5149 11237522
39. Sharpless NE INK4a/ARF: A multifunctional tumor suppressor locus Mutat Res 2005, 576(1-2):22-38. 15878778
40. Chen J Lui WO Vos MD Clark GJ Takahashi M Schoumans J Khoo SK Petillo D Lavery T Sugimura J Astuti D Zhang C Kagawa S Maher ER Larsson C Alberts AS Kanayama HO Teh BT The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas Cancer Cell 2003, 4(5):405-413. 10.1016/S1535-6108(03)00269-1 14667507
41. Ntougkos E Rush R Scott D Frankenberg T Gabra H Smyth JF Sellar GC The IgLON family in epithelial ovarian cancer: Expression profiles and clinicopathologic correlates Clin Cancer Res 2005, 11(16):5764-5768. 10.1158/1078-0432.CCR-04-2388 16115914
42. Stallings RL Nair P Maris JM Catchpoole D McDermott M O'Meara A Breatnach F High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma Cancer Res 2006, 66(7):3673-3680. 10.1158/ 0008-5472.CAN-05-4154 16585193
43. Hoebeeck J Michels E Menten B Van Roy N Eggert A Schramm A De Preter K Yigit N De Smet E De Paepe A Laureys G Vandesompele J Speleman F High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors Int J Cancer 2007, 120(3):533-538. 10.1002/ijc.22326 17096344
44. Agathanggelou A Dallol A Zochbauer-Muller S Morrissey C Honorio S Hesson L Martinsson T Fong KM Kuo MJ Yuen PW Maher ER Minna JD Latif F Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers Oncogene 2003, 22(10):1580-1588. 10.1038/sj.onc.1206243 12629521
45. Astuti D Agathanggelou A Honorio S Dallol A Martinsson T Kogner P Cummins C Neumann HP Voutilainen R Dahia P Eng C Maher ER Latif F RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours Oncogene 2001, 20(51):7573-7577. 10.1038/sj.onc.1204968 11709729
46. Saito-Ohara F Imoto I Inoue J Hosoi H Nakagawara A Sugimoto T Inazawa J PPM1D is a potential target for 17q gain in neuroblastoma Cancer Res 2003, 63(8):1876-1883. 12702577
47. Vandesompele J Michels E De Preter K Menten B Schramm A Eggert A Ambros PF Combaret V Francotte N Antonacci F De Paepe A Laureys G Speleman F Van Roy N Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics Int J Cancer 2008, 122(5):1177-1182. 10.1002/ijc.23156 17973261
48. Munnia A Schutz N Romeike BF Maldener E Glass B Maas R Nastainczyk W Feiden W Fischer U Meese E Expression, cellular distribution and protein binding of the glioma amplified sequence (GAS41), a highly conserved putative transcription factor Oncogene 2001, 20(35):4853-4863. 10.1038/ sj.onc.1204650 11521196
49. Van Roy N Forus A Myklebost O Cheng NC Versteeg R Speleman F Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP Cancer Genet Cytogenet 1995, 82(2):151-154. 10.1016/0165-4608(95)00034-M 7664245
50. Corvi R Savelyeva L Breit S Wenzel A Handgretinger R Barak J Oren M Amler L Schwab M Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma Oncogene 1995, 10(6):1081-1086. 7700632
51. Woods DB Vousden KH Regulation of p53 function Exp Cell Res 2001, 264(1):56-66. 10.1006/excr.2000.5141 11237523
52. Hosoi G Hara J Okamura T Osugi Y Ishihara S Fukuzawa M Okada A Okada S Tawa A Low frequency of the p53 gene mutations in neuroblastoma Cancer 1994, 73(12):3087-3093. 10.1002/ 1097-0142(19940615)73:12<3087::AID-CNCR2820731230>3.0.CO;2-9 8200007
53. Imamura J Bartram CR Berthold F Harms D Nakamura H Koeffler HP Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification Cancer Res 1993, 53(17):4053-4058. 8358734
54. Komuro H Hayashi Y Kawamura M Hayashi K Kaneko Y Kamoshita S Hanada R Yamamoto K Hongo T Yamada M Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas Cancer Res 1993, 53(21):5284-5288. 8221663
55. Vogan K Bernstein M Leclerc JM Brisson L Brossard J Brodeur GM Pelletier J Gros P Absence of p53 gene mutations in primary neuroblastomas Cancer Res 1993, 53(21):5269-5273. 8221661
56. Esteller M Tortola S Toyota M Capella G Peinado MA Baylin SB Herman JG Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status Cancer Res 2000, 60(1):129-133. 10646864
57. Ho GH Calvano JE Bisogna M Abouezzi Z Borgen PI Cordon-Cardo C van Zee KJ Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma Breast Cancer Res Treat 2001, 65(3):225-232. 10.1023/ A:1010686518990 11336244
58. Oliner JD Kinzler KW Meltzer PS George DL Vogelstein B Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 1992, 358(6381):80-83. 10.1038/358080a0 1614537
59. Auerkari EI Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis Oral Oncol 2006, 42(1):5-13. 10.1016/ j.oraloncology.2005.03.016 15978859
60. Nannya Y Sanada M Nakazaki K Hosoya N Wang L Hangaishi A Kurokawa M Chiba S Bailey DK Kennedy GC Ogawa S A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays Cancer Res 2005, 65(14):6071-6079. 10.1158/0008-5472.CAN-05-0465 16024607
61. Yamamoto G Nannya Y Kato M Sanada M Levine RL Kawamata N Hangaishi A Kurokawa M Chiba S Gilliland DG Koeffler HP Ogawa S Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays Am J Hum Genet 2007, 81(1):114-126. 1950910 17564968 10.1086/518809